Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
- PMID: 32451271
- PMCID: PMC7192093
- DOI: 10.1053/j.jvca.2020.04.041
Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications
Abstract
The coronavirus disease-2019 (COVID-19) has become a global pandemic. It has spread to more than 100 countries, and more than 1 million cases have been confirmed. Although coronavirus causes severe respiratory infections in humans, accumulating data have demonstrated cardiac complications and poor outcome in patients with COVID-19. A large percent of patients have underlying cardiovascular disease, and they are at a high risk of developing cardiac complications. The basics of the virus, the clinical manifestations, and the possible mechanisms of cardiac complications in patients with COVID-19 are reviewed. Before an effective vaccine or medicine is available, supportive therapy and identifying patients who are at high risk of cardiac complications are important.
Keywords: cardiac complications; cardiac injury; coronavirus disease-2019; inflammatory factors; pneumonia.
© 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
None.
Figures
References
-
- Johns Hopkins University and Medicine. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins. Available at: https://coronavirus.jhu.edu/map.html. Accessed April 15.
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24 [E-pub ahead of print] - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
